2017 December - Human therapeutic products allowed for veterinary use by APVMA

The Australian Pesticides and Veterinary Medicines Authority (APVMA) has recently issued a permit allowing for a number products registered by the Therapeutic Goods Administration (TGA) to be used in animals.

Permit 13662 now allows use of the following products for animal treatment:

  1. Mexiletine hydrochloride USP (TEVA), containing either 100mg, 150mg, 200mg or 250 mg Mexiletine Hydrochloride USP per capsule.
  2. Succicaptal capsules, containing 200mg Dimercaptosuccinic acid (succimer, DMSA) per capsule
  3. Thiola tablets and Captimer tablets, containing 100mg Tiopronin per tablet
  4. Pyrazinamide tablets, containing 500mg Pyrazinamide per tablet
  5. Cycloblastin tablets and Edoxan tablets, containing 50mg Cyclophosphamide anhydrous ANHYDROUS
  6. Oncaspar (Pegaspargase) 3750 I.U. 5 mL injectable
  7. Sii BCG Vaccine and Biomed-Lublin BCG 10 AntiTuberculosis Vaccine
  8. Enlon containing 150mg Endrophonium chloride /15mL injection